Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-05T07:49:24.109Z Has data issue: false hasContentIssue false
  • English
  • Français

Increased Use of Pneumococcal Vaccination in a Medicine ClinicFollowing Initiation of a Quality Assessment Monitor

Published online by Cambridge University Press:  21 June 2016

Joanne K. Tobacman
Joanne K. Tobacman*
Affiliation:
Department of Internal Medicine, the College of Medicine, The University of Iowa, Iowa City, Iowa
*
Department of Internal Medicine, C312 GH, The University of Iowa Hospitals and Clinics, Iowa City, IA 52242
Get access Rights & Permissions [Opens in a new window]

Abstract

Obectives:

To determine the use of pneumococcal vaccination in a general medicine ambulatory clinic and the effect of a quality assessment monitor on use.

Design:

A prospective 8-month (October 1990 through May 1991) survey and 8-month (October 1989 through May 1990) retrospective survey of use of pneumococcal vaccination in the clinic.

Setting:

A general medicine clinic where patients are seen for their first internal medicine clinic visit at The University of Iowa Hospitals and Clinics, Iowa City, Iowa.

Patients:

One thousand sixty adult patients who presented to the clinic during the study interval.

Interventions:

The use of the form constituted an intervention.

Results:

Use of pneumococcal vaccination was increased more than 5 times over the baseline level following implementation of the quality assessment monitor.

Conclusions:

Underuse of pneumococcal vaccination occurred in this general medicine clinic, and the introduction of a quality assessment monitor constituted an intervention that significantly increased the use of pneumococcal vaccination.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 13 , Issue 3 , March 1992 , pp. 144 - 146
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1992 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Recommendations of the Immunization Practices Advisory Committee. MMWR. 1989;38:64–76.Google Scholar
2. LaForce, FM. Adult immunizations: are they worth the trouble?] Gen Intern Med. 1990;5 (suppl) :S57–S61.CrossRefGoogle ScholarPubMed
3. Shapiro, ED, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991;325:1453–1460.CrossRefGoogle ScholarPubMed
4. Simberkoff, MS, Cross, AO, Al-Ibrahim, M, et al. Efficacy of pneumococcal vaccine in high-risk patients: results of a Veterans Administration cooperative study. N Engl J Med. 1986;315:1318–1327.10.1056/NEJM198611203152104CrossRefGoogle ScholarPubMed
5. Shapiro, ED. Pneumococcal vaccine failure. N Engl J Med. 1987;316:1272–1273.Google Scholar
6. Gaillat, J, Zmirou, D, Mallaret, MR, et al. Essai clinique du vaccin antipneumococcique chez des personnes agees vivant en institution. Rev Epidemiol Sante Publique. 1985;33:437–444.Google Scholar
7. Williams, WW, Hickson, MA, Kane, MA, Kendal, AP, Spika, JS, Hinman, AR. Immunization policies and vaccine coverage among adults. Ann Intern Med. 1988;108:616–625.10.7326/0003-4819-108-4-616CrossRefGoogle Scholar